Shop

The Food and Drug Administration has been slow to stop an alarming number of inaccurate drug advertisements, leaving consumers and the doctors that actually prescribe the medicines vulnerable to false or misleading messages. The investigation found ads that minimized prescription drug risks, exaggerated efficacy, made false claims of superiority over competing products, promoted unapproved uses of an approved drug, or promoted use of a drug still in the experimental stage. Such drug ads may contribute to excessive or inappropriate prescribing and to soaring prescription drug spending.